Investigating Coordinated Removal of Old and Synthesis of New Materials in Neurons and how These Processes are Disrupted in FTD
Principal Investigator
Sarah Hill, PhD
The National Institute of Neurological Disorders and Stroke
Bethesda, MD, USA
About the Research Project
Program
Award Type
Postdoctoral Fellowship
Award Amount
$200,000
Active Dates
September 01, 2020 - August 31, 2022
Grant ID
A20201086F
Mentor(s)
Michael Ward, MD, PhD, Howard Hughes Medical Institute, Janelia Research Campus
Jennifer Lippincott-Swartz, PhD, Howard Hughes Medical Institute, Janelia Research Campus
Goals
Similar to how grocery stores maintain a full shelf of milk cartons by continually selling milk and obtaining new cartons, cells must balance the removal of old and synthesis of new materials. In neurons, insufficient removal of materials or defects in synthesis, lead to loss of neuronal function, accumulation of toxic aggregates, and ultimately neuron death, contributing to the pathogenesis of neurodegenerative diseases such as Frontotemporal Dementia (FTD). In this proposal I will examine how the distinct processes of removal and synthesis are interrelated. I will use imaging to determine their physical and temporal relationship, drugs to block removal and determine the effects on synthesis, and I will use neurons created from human cells to best determine the extent to which these processes occur during FTD.
Summary
Similar to how grocery stores maintain a full shelf of milk cartons by continually selling milk and obtaining new cartons, cells must balance the removal of old and synthesis of new materials. In neurons, insufficient removal of materials or defects in synthesis, lead to loss of neuronal function, accumulation of toxic aggregates, and ultimately neuron death, contributing to the pathogenesis of neurodegenerative diseases such as Frontotemporal Dementia (FTD). In this proposal I will examine how the distinct processes of removal and synthesis are interrelated. I will use imaging to determine their physical and temporal relationship, drugs to block removal and determine the effects on synthesis, and I will use neurons created from human cells to best determine the extent to which these processes occur during FTD.
Related Grants
Alzheimer's Disease Research
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
Alzheimer's Disease Research
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Alzheimer's Disease Research
Probing the Novel Roles of Neuromodulators in Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Fikri Birey, PhD
Current Organization
Emory University
Probing the Novel Roles of Neuromodulators in Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Fikri Birey, PhD
Current Organization
Emory University